Compare XHR & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XHR | SDGR |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | N/A | 2020 |
| Metric | XHR | SDGR |
|---|---|---|
| Price | $15.00 | $17.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | $14.14 | ★ $26.25 |
| AVG Volume (30 Days) | 798.0K | ★ 846.9K |
| Earning Date | 10-31-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.71% | N/A |
| EPS Growth | ★ 139.32 | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $1,074,772,000.00 | $256,951,000.00 |
| Revenue This Year | $4.52 | $23.69 |
| Revenue Next Year | $3.04 | $20.46 |
| P/E Ratio | $27.23 | ★ N/A |
| Revenue Growth | 4.29 | ★ 32.90 |
| 52 Week Low | $8.55 | $15.99 |
| 52 Week High | $16.07 | $28.47 |
| Indicator | XHR | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 70.00 | 47.32 |
| Support Level | $13.39 | $17.02 |
| Resistance Level | $15.31 | $19.04 |
| Average True Range (ATR) | 0.33 | 0.78 |
| MACD | 0.11 | 0.07 |
| Stochastic Oscillator | 84.13 | 33.00 |
Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The firm's customer groups include transient business, group business, and contract business.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.